We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A

203 hedge funds and large institutions have $2.05B invested in Bio-Rad Laboratories Class A in 2013 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 81 increasing their positions, 62 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

336% more call options, than puts

Call options by funds: $1.54M | Put options by funds: $353K

35% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 20

31% more repeat investments, than reductions

Existing positions increased: 81 | Existing positions reduced: 62

3% more funds holding

Funds holding: 198203 (+5)

4% more capital invested

Capital invested by funds: $1.97B → $2.05B (+$77.9M)

0.36% less ownership

Funds ownership: 75.05%74.69% (-0.36%)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

Holders
203
Holders Change
+5
Holders Change %
+2.53%
% of All Funds
6.58%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.1%
New
27
Increased
81
Reduced
62
Closed
20
Calls
$1.54M
Puts
$353K
Net Calls
+$1.19M
Net Calls Change
+$222K
Name Holding Trade Value Shares
Change
Change in
Stake
ACM
1
Atlanta Capital Management
Georgia
$201M +$629K +5,337 +0.3%
RA
2
Royce & Associates
New York
$137M -$12.5M -105,987 -8%
AI
3
Ariel Investments
Illinois
$129M +$9.93M +84,207 +8%
Vanguard Group
4
Vanguard Group
Pennsylvania
$123M +$2.93M +24,885 +2%
LCS
5
Levin Capital Strategies
New York
$102M +$15M +127,355 +17%
CIP
6
Champlain Investment Partners
Vermont
$92.2M +$5.05M +42,835 +6%
State Street
7
State Street
Massachusetts
$67.1M -$1.1M -9,297 -2%
BFA
8
BlackRock Fund Advisors
California
$66.8M +$2.5M +21,157 +4%
UBS AM
9
UBS AM
Illinois
$66.4M -$3.21M -27,200 -5%
BIT
10
BlackRock Institutional Trust
California
$63.7M -$11.4M -96,539 -15%
SIG
11
Senator Investment Group
New York
$62.4M +$2.48M +21,000 +4%
Wells Fargo
12
Wells Fargo
California
$49.9M +$9.55M +80,975 +24%
RFC
13
Russell Frank Company
Washington
$47.3M +$5.71M +48,415 +14%
Morgan Stanley
14
Morgan Stanley
New York
$44M -$827K -7,012 -2%
Fisher Asset Management
15
Fisher Asset Management
Washington
$41.5M -$110K -935 -0.3%
FPA
16
First Pacific Advisors
California
$35.7M -$70.8K -600 -0.2%
ICM
17
Intrepid Capital Management
Florida
$34.6M -$2.55M -21,608 -7%
MAA
18
Managed Account Advisors
New Jersey
$34.2M +$527K +4,469 +2%
GIM
19
Granahan Investment Management
Massachusetts
$31.3M -$2.52M -21,350 -7%
Northern Trust
20
Northern Trust
Illinois
$30.2M +$1.82M +15,444 +6%
American Century Companies
21
American Century Companies
Missouri
$29.5M +$29.6M +250,650 New
ICOM
22
Investment Counselors of Maryland
Maryland
$26.2M -$2.7M -22,900 -9%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$24.6M +$211K +1,789 +0.9%
FWIA
24
Fort Washington Investment Advisors
Ohio
$23.4M +$23.5M +198,925 New
Invesco
25
Invesco
Georgia
$22.4M +$333K +2,820 +2%

BIO Hedge Fund Activity: Q3 2013 in Review

203 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q3 2013, worth a combined $2.05B — up 3.9% from $1.97B a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new BIO positions and 20 closed out — a net gain of 7 holders — while 81 added to existing stakes and 62 trimmed.

The largest buyer was American Century Companies, opening a new position worth an estimated $29.6M. The largest seller was Brown Brothers Harriman & Co, cutting an estimated $72.6M.

  • 203 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q3 2013, up from 198 in Q2 2013.
  • Funds reported $2.05B of Bio-Rad Laboratories Class A stock for Q3 2013, up 3.9% quarter-over-quarter.
  • 27 funds opened new Bio-Rad Laboratories Class A positions in Q3 2013 and 20 closed out, a net change of +7 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q3 2013 was American Century Companies, an estimated $29.6M added.
  • The largest Bio-Rad Laboratories Class A seller in Q3 2013 was Brown Brothers Harriman & Co, an estimated $72.6M sold.

Based on aggregated 13F filings for Q3 2013.